Industry
Pharmaceuticals
Topic
All Topics
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Pharmaceuticals
... negotiations to buy the farms for $100 million. That is until CK Life Sciences came in. The group, backed by Chinese billionaire Li Ka-shing, is ...
... private equity firm run by two of the drivers of vitamins giant Swisse's global rise has taken a 25 per cent stake in plant-based supplements ...
... SAN DIEGO, Feb. 25, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq:LJPC) today announced that an abstract, entitled "Effect of Disease Severity ...
... and Canada. Terms of the deal were not disclosed. Settlement: Silver Spring-based United Therapeutics has entered into a settlement agreement with Actavis Laboratories that will ...
... to provide meaningful protection against accidental exposure. Based on the positive results, Aimmune Therapeutics expects to seek US approval for its preventative peanut allergy therapy ...
... Last month, for instance, immunotherapy pioneer Juno Therapeutics sold to pharma giant Celgene in a deal valued at $9 billion. Five years earlier, Seattle-based Juno ...
... Kilsheimer LLP (http://www.kaplanfox.com) is investigating claims on behalf of investors of Synergy Pharmaceuticals Inc. ("Synergy" or the "Company") (NASDAQ: SGYP). Investors who purchased Synergy securities ...
... is investigating potential securities claims on behalf of shareholders of United Therapeutics Corporation (NASDAQ: UTHR) resulting from allegations that United Therapeutics may have issued materially ...
... VANCOUVER, British Columbia, Feb. 23, 2018 -- Harvest One Cannabis Inc. (TSXV:HVT) ("Harvest One" or the "Company") is pleased to announce that it has provided ...
... bets big on a cancer drug WHEN Ken Frazier, chief executive of Merck, an American pharmaceutical giant, started his job in 2011, he had a ...
... officials granted an accelerated approval to the treatment, Xofluza from pharmaceutical maker Shionogi, last week. It could soon prove to be a significant competitor to ...
... officials granted an accelerated approval to the treatment, Xofluza from pharmaceutical maker Shionogi, last week. It could soon prove to be a significant competitor to ...
... doubts regarding the ability of UPS to contain its capital spending needs. Allergan – SunTrust Robinson Humphrey began coverage of the drugmaker with a "buy" ...
... class action lawsuit on behalf of purchasers of the securities of TESARO, Inc. (NASDAQ: TSRO) from March 14, 2016 through January 12, 2018, inclusive (the ...
... paid $110 million in 2014 to acquire its Albuquerque facilities from Oso Biopharmaceuticals Manufacturing LLC, a homegrown New Mexico company that itself acquired the injectable-drug ...
... When Teva Pharmaceuticals announced recently that it would begin selling a copycat version of ...
... series B last May and licensed its lead candidate from Novartis. FierceBiotech Hikma PharmaceuticalsSiggi Olafsson became CEO. Siggi Olafsson’s departure from Teva's generics CEO post ...
... Teva is working to consolidate seven U.S. offices under one roof, and that ...
... After an approval late last year for its next big diabetes offering, Novo Nordisk has secured 2018 formulary coverage from leading U.S. pharmacy benefit manager ...
... market, with sales, price, revenue and market share for each manufacturer, covering Teva Skin Care, GNC, Nutrilite, Xi'an Tianyi, Hunan Nutramax, Refine Biology, Xi'an Mingze, ...
... Therapeutics, Inc. (OTC: ENDV), 22nd Century Group, Inc. (NYSE: XXII), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), Emerald Health Therapeutics, Inc. (TSX-V: EMH) (OTC: EMHTF), Delcath ...
... ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel therapies ...
... Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use ...
... SAN DIEGO, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today provided an update on the progress of exploring commercialization ...
... PHOENIX, Feb. 23, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical ...
... an estimated market cap topping $300 million, is definitely one to watch. Aphria(OTCQB: APHQF) (TSX: APH) was founded in 2011 and is headquartered in Leamington, ...
... Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in ...
... Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use ...
... China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated ...
... WESTLAKE VILLAGE, Calif., Feb. 23, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2017 fourth quarter and full year financial results ...
... Pfizer Inc. today announced the election of Albert Bourla, DVM, Ph.D. to its ...
... (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) and Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) (Ultragenyx) today announce that Crysvita (burosumab) has received a positive ...
... Inc. (NYSE:MMI), Lockheed Martin Corporation (NYSE:LMT), Coherus BioSciences, Inc. (NASDAQ:CHRS), and Capricor Therapeutics, Inc. (NASDAQ:CAPR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified ...
... for ALIS, a one-time payment to reduce the royalty owed to PARI Pharma GmbH and higher compensation and related expenses due to an increase in ...
... RICHMOND HILL, Ontario, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company ...
... Puma Biotechnology, Inc. (Nasdaq: PBYI) announced that the Committee for Medicinal Products for Human Use ...
... DUBLIN, Ireland and TREVOSE, Pa., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and ...
... AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and ...
... Mallinckrodt plc(NYSE: MNK), a leading global specialty pharmaceutical company, today announced the U.S. Food ...
... investment community. Today we are offering reports on ANAB, ANTH, ARLZ, and PETX which can be accessed for free by signing up tohttp://www.wallstequities.com/registration. Pre-market today, ...
... Atossa Genetics Inc. (NASDAQ: ATOS), Palatin Technologies Inc. (NYSEAMER: PTN), Adamis Pharmaceuticals Corp. (NASDAQ: ADMP), and Perrigo Co. PLC (NYSE: PRGO). Companies in the Healthcare ...
... Tests carried out by Researchers from UNIGE, HUG, and AB2 Bio Ltd., a startup from Lake Geneva's Health Valley on a drug to ...
... Marapharm Ventures Inc. ('Marapharm') is pleased to announce that the CSE (the 'Canadian Securities ...
... Tokyo, Japan - Kyowa Hakko Kirin Co., Ltd. ('Kyowa Hakko Kirin') hereby announces that the Audit & Supervisory Board ...
... Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the rollout in North ...
... Melbourne, Australia - Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that it has received a $ 3.7M ...
... NEW YORK - Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) a biopharmaceutical company focused on the development of therapeutics for ...
... KNOXVILLE - Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com), ('Provectus' or the 'Company'), a clinical-stage biotechnology company developing the first small molecule ...
... - Building on its commitment to accelerate scientific research and science education, Merck, a leading science and technology company, today announced nine new or expanded ...
... securing our first licensing agreement for our most advanced candidate drug PledOx. PledPharma's first commercial Cooperation agreement In November, we announced that the Japanese pharmaceutical ...
... SAN DIEGO - La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the development of innovative therapies intended ...
... Mumbai, India - Merck, a leading science and technology company, today announced that it will invest ...
... TUCSON, Arizona - Cancer Prevention Pharmaceuticals, Inc. (CPP), a private clinical stage biotech company developing novel therapeutics to ...
... MEMPHIS, Tenn. - GTx, Inc. (Nasdaq: GTXI) today announced the acceptance of an abstract on clinical results ...
... - December of 2017) Effective July 31, 2017, Jaguar merged with Napo Pharmaceuticals, Inc. (Napo) and acquired its first-in-class, FDA-approved anti-secretory human prescription drug product, ...
... NEW HAVEN - Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical stage biopharmaceutical company focused on developing inhibitors ...
... The Woodlands, TX - VGXI announced today they have broken ground on a 5,000 square foot expansion ...
... CAMBRIDGE, Mass. - Sage Therapeutics, Inc. (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering ...
... secret to constructing a sustainable and stable building is good foundations. At UCB, we take this approach when preparing our company for future growth. As ...
... STAMFORD, Conn. - Loxo Oncology, Inc. (Nasdaq: LOXO), a biopharmaceutical company innovating the development of highly selective medicines ...
... Swedish Orphan Biovitrum AB (publ) (Sobi) today announces its results for the fourth quarter and full-year 2017. Total ...
... December 31, 2017, after the market close on Thursday, March 8, 2018. Pernix management will also host a conference call at 4:30pm Eastern Time to ...
... surpasses 30% rEBITDA margin - one year ahead of guidance In July, UCB filed a marketing authorization in the EU for Briviact for children with ...
... year 2017 financial results and operational highlights on Thursday, March 8th, 2018. OncoMed management will host a conference call and webcast at 4:30 p.m. Eastern ...
... Corporate Wire Date: 23 February 2018 03:56 EST ORIGINAL ANNOUNCEMENT [Text] Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced ...
... Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ Paris - February 23, 2018 - Sanofi announced today ...
... He is the co-founder of three biotechnology companies: NeuroVir Therapeutics Inc., Xenon Pharmaceuticals Inc., and Aspreva Pharmaceuticals Corp. Dr. Hayden sits on different boards including ...
... Bagsvaerd, Denmark, 23 February 2018 - The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 22 March 2018 at 2.00 pm ...
... for the content of this announcement. Basel, Switzerland, February 23, 2018 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has commenced enrollment in the ...
... CANADIAN RESULTS MedReleaf (TSX:LEAF) reported loss for the quarter-ended 31 December 2017 of CAD5.0m ($US4.0m). ...
... Wire Date: 22 February 2018 21:34 EST ORIGINAL ANNOUNCEMENT [Text] Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX: JWEL) today reported financial results for ...
... EST ORIGINAL ANNOUNCEMENT [Text] RICHMOND HILL, Ontario, Feb. 22, 2018 -- Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company ...
... [Text] Canada NewsWire TORONTO, Feb. 22, 2018 TORONTO, Feb. 22, 2018 - Nuuvera Inc. (the "Company" or "Nuuvera") (TSXV: NUU), is pleased to announce that ...
... to announce the completion of the sale of its shares of GrowPros MMP Inc. ("GrowPros") to North Bud Farms Inc. (the "Purchaser" or "North Bud") ...
... 12: NetworkNewsAudio Covers NeutriSci International Inc.'s Release on Recent R&D MOU with Scientus Pharma To read the original press release, visit To hear the NetworkNewsAudio ...
... Blackmores is grappling with increased competition in China and shortages of ingredients such ...
... poised to be snapped up by Americans after global pharmaceutical giant Merck & Co moved on Viralytics in a $502 million deal to secure its ...
Subscribe now for full coverage on Pharmaceuticals
Start My Free Trial